News
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...
Abstract #: 306-OR Presentation Form: Oral presentation Time: 2025 June 23, 14:15 PM – 14:30 PM(CST) Presenter: Dr. Lei Qian, Innovent Biologics Title: A novel antibody-peptide conjugate targeting ...
New study examines benefits of continuous glucose monitoring (CGM) in people with type 2 diabetes (T2D) using glucagon-like ...
Hosted on MSN11d
Ascletis presents new data on ASC30 and ASC47 at ADA 2025HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary ... Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, ...
18d
Zacks Small Cap Research on MSNIMNN: Momentum Continues with Presentations at ASCO and ESMO Gynaecological Cancers…IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Momentum Continues with Presentations at ASCO and ESMO Imunon, Inc.
Overall ratings poster template (PowerPoint version) (pptx, 305.48kB, English) Additional poster template for services with ratings at core service level (PowerPoint version) (pptx, 393.74kB, English) ...
PowerPoint’s layouts and templates hold the key to transforming your ideas into visually striking presentations that captivate your audience. These tools aren’t just for designers—they’re ...
If you're the type who has trouble with layout concepts or simply needs to accelerate the presentation process, these templates are lifesavers. If you're a student, teacher, entrepreneur ...
In contrast to an oral presentation, a “poster” is a visual ... one available from WebAIM or use one of the pre-designed templates available from Boise State. When you finish designing your poster, ...
Poster presentation at the Society for Research on Nicotine & Tobacco Annual Meeting. New Orleans. March 12–15, 2025. Cohen JE. Packaged to persuade: Building the scientific case for plain and ...
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results